Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.

The marginal difference in the percent expression as well as MFI of these molecules in HD-DCs and MM-DCs did not reach statistical significance (Fig. 1f ).

also in 111,027 other papers